Valneva SE (VALN) Retained Earnings (2020 - 2026)
Valneva SE's (VALN) quarterly Retained Earnings came in at $99.5 million in Q1 2026, up 23.76% year-on-year from $80.4 million in Q1 2025, and up 2.6% quarter-over-quarter from $97.0 million in Q4 2025.
Valneva SE (VALN) Retained Earnings (2020 - 2026) Analysis & Trends
Valneva SE has disclosed Retained Earnings across 7 years of filings, most recently posting $99.5 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at $99.5 million, up 23.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $99.5 million (up 23.76% YoY), and the FY2025 annual result was $97.0 million, up 23.98% from the prior year.
- Retained Earnings came in at $99.5 million for Q1 2026 at Valneva SE, up from $97.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $99.5 million in Q1 2026 to a low of -$344.5 million in Q1 2022.
- The 5-year median for Retained Earnings is $73.0 million (2024), against an average of $48.0 million.
- Across the five-year window, Retained Earnings soared 289.21% in 2023 and gained 10.19% in 2025, its largest moves.
- Valneva SE's Retained Earnings stood at $18.0 million in 2022, then jumped by 289.21% to $70.0 million in 2023, then grew by 11.7% to $78.2 million in 2024, then climbed by 23.98% to $97.0 million in 2025, then increased by 2.6% to $99.5 million in 2026.
- The last three Retained Earnings figures came in at $99.5 million (Q1 2026), $97.0 million (Q4 2025), and $95.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -838.07 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | 99.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.50 Mn |
| Dec 31, 2025 | 96.99 Mn |
| Sep 30, 2025 | 95.14 Mn |
| Jun 30, 2025 | 89.57 Mn |
| Mar 31, 2025 | 80.40 Mn |
| Dec 31, 2024 | 78.22 Mn |
| Sep 30, 2024 | 79.54 Mn |
| Jun 30, 2024 | 74.46 Mn |
| Mar 31, 2024 | 72.96 Mn |
| Dec 31, 2023 | 70.03 Mn |
| Sep 30, 2023 | 67.72 Mn |
| Jun 30, 2023 | 66.65 Mn |
| Mar 31, 2023 | 62.65 Mn |
| Dec 31, 2022 | 17.99 Mn |
| Sep 30, 2022 | 52.22 Mn |
| Jun 30, 2022 | 56.00 Mn |
| Mar 31, 2022 | -344.53 Mn |
| Dec 31, 2021 | -10.89 Mn |
| Dec 31, 2020 | -1.07 Mn |